黑色素细胞痣与皮肤黑色素瘤中维生素D受体的免疫组化表达:病例对照研究
该病例对照研究分析了54例良性真皮痣和55例恶性黑色素瘤组织中维生素D受体(VDR)的核与细胞质免疫组化染色。黑色素瘤中细胞质VDR缺失与Clark分级、肿瘤分期及AJCC pTNM分期相关,提示细胞质VDR缺失可能是预后因素。
要点
- 良性真皮痣的细胞质VDR阳性率显著高于黑色素瘤。
- 黑色素瘤中细胞质VDR缺失与肿瘤分期和Clark分级相关。
- 细胞质VDR缺失可能是黑色素瘤的预后因素。
核心结论
- 黑色素瘤与良性痣相比存在VDR表达和定位的改变,细胞质VDR缺失可能与肿瘤进展相关。
研究设计与样本
- 病例对照研究,评估54例良性真皮痣和55例恶性黑色素瘤组织的VDR免疫组化染色。
临床怎么用
- 细胞质VDR免疫组化表达可能有助于区分良性痣与黑色素瘤。
- 细胞质VDR缺失或可辅助评估黑色素瘤预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitamin D deficiency is associated with higher risk of cancer, possibly due to its antiproliferative, antiangiogenic, proapoptotic, cell-differentiating and anti-invasive effects. The anticarcinogenic role of vitamin D in melanoma is still a matter of debate. Loss of nuclear and cytoplasmic vitamin D receptor (VDR) expression in melanoma cells has been reported. OBJECTIVES: To analyse VDR immunohistochemical expression in benign dermal naevi (DN) and malignant melanoma (MM). METHODS: A case-control study evaluated nuclear and cytoplasmic VDR immunohistochemical staining in 54 DN and 55 MM tissue samples. RESULTS: There was significantly higher cytoplasmic VDR positivity in DN compared with MM (59% vs. 16%, P < 0·001). The mean VDR cytoplasmic expression was also higher in DN vs. MM (P < 0·001). No differences in nuclear VDR positivity were observed between groups, but mean nuclear VDR expression was significantly lower in DN vs. MM (P = 0·02). The loss of cytoplasmic VDR in MM was associated with Clark level, tumour staging and American Joint Committee on Cancer pTNM staging (P=0·004, 0·009 and 0·02, respectively). CONCLUSIONS: Alterations in VDR expression and localization are found in MM compared with DN. Loss of cytoplasmic VDR was associated with melanoma tumour size, suggesting that loss of cytoplasmic VDR may be a prognostic factor.
引用
- Del Puerto C, Navarrete-Dechent C, Molgó M, et al. Immunohistochemical expression of vitamin D receptor in melanocytic naevi and cutaneous melanoma: a case-control study. Br J Dermatol. 2018. PMID: 29106699. doi:10.1111/bjd.16103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。